Sequana Medical announces Annual General Meeting of Shareholders on 25 May 2023 Publication of Annual Report 2022
Ghent, Belgium – 25 April 2023 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, today invites the holders of securities issued by the Company to attend the Annual General Meeting of Shareholders on Thursday, 25 May 2023. Furthermore, the annual report for the financial year 2022 has been published on Sequana Medical's website and can be accessed here.
The items on the agendas of the meeting include (amongst other things) the proposed approval of a number of resolutions relating to the financial year ended on 31 December 2022 and the application of Article 7:228 of the Belgian Companies and Associations Code.
The Annual Meeting of Shareholders will take place at the Company's registered offices in Ghent and will start at 09:00 am CEST. The full convening notice with the agenda and proposed resolutions can be accessed on the Sequana Medical website: www.sequanamedical.com/investors/shareholder-information.
The Company recommends the holders of its securities to use e-mail for all communications with the Company regarding the Annual General Meeting of Shareholders. The Company's e-mail address for such communications is: IR@sequanamedical.com.